We are live on
!
Find out more
KAM
Kazazian Asset Management Portfolio holdings
AUM
$111M
1-Year Est. Return
29.02%
This Fund
S&P 500
This Quarter
Est. Return
-4.9%
1 Year Est. Return
+29.02%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$123M
AUM Growth
-$7.89M
(-6%)
Cap. Flow
+$3.08M
Cap. Flow
% of AUM
2.51%
Top 10 Holdings %
Top 10 Hldgs %
74.13%
Holding
79
New
18
Increased
10
Reduced
9
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$4.58M |
| 2 |
Alibaba
BABA
|
+$4.07M |
| 3 |
AdvisorShares Pure US Cannabis ETF
MSOS
|
+$2.3M |
| 4 |
FTAI Aviation
FTAI
|
+$1.89M |
| 5 |
Baidu
BIDU
|
+$1.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$2.87M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$2.12M |
| 3 |
LegalZoom.com
LZ
|
+$1.83M |
| 4 |
Pfizer
PFE
|
+$1.58M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 32.57% |
| 2 | Consumer Discretionary | 28.58% |
| 3 | Financials | 18.83% |
| 4 | Technology | 8.32% |
| 5 | Healthcare | 3.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cognex
CGNX
$10.8B
| $673K | 0.55% |
22,564
+2,000
| +10% | +$70.4K |
|
27
Bank of America
BAC
$447B
| $663K | 0.54% |
15,879
| – | – |
|
28
Indivior Pharmaceuticals
INDV
$4.54B
| $630K | 0.51% |
79,425
-53,758
| -40% | -$565K |
|
|
MRUS
29
CALL
DELISTED
Merus
MRUS
| $610K | 0.5% |
14,500
+4,900
| +51% | +$214K |
|
30
KraneShares CSI China Internet ETF
KWEB
$5.76B
| $584K | 0.47% |
16,723
| – | – |
|
|
31
Pfizer
PFE
$154B
| $457K | 0.37% |
18,050
-60,250
| -77% | -$1.58M |
|
32
MongoDB
MDB
$33.5B
| $435K | 0.35% |
2,478
-2,800
| -53% | -$682K |
|
33
SelectQuote
SLQT
$123M
| $430K | 0.35% |
128,700
+6,900
| +6% | +$29.3K |
|
|
NESR
34
National Energy Services Reunited Corp
NESR
$3.61B
| $422K | 0.34% |
+57,300
| New | +$495K |
|
35
BridgeBio Pharma
BBIO
$16.6B
| $409K | 0.33% |
11,840
-1,680
| -12% | -$56.6K |
|
36
Cytokinetics
CYTK
$10.5B
| $394K | 0.32% |
9,796
+4,560
| +87% | +$210K |
|
37
Hovnanian Enterprises
HOV
$772M
| $377K | 0.31% |
+3,600
| New | +$434K |
|
|
NBIS
38
Nebius Group N.V.
NBIS
$46.7B
| $369K | 0.3% |
+17,466
| New | +$575K |
|
39
Regeneron Pharmaceuticals
REGN
$83.2B
| $355K | 0.29% |
560
| – | – |
|
40
Shopify
SHOP
$200B
| $349K | 0.28% |
3,650
| – | – |
|
41
Trade Desk
TTD
$6.29B
| $348K | 0.28% |
+6,362
| New | +$576K |
|
|
42
CALL
BridgeBio Pharma
BBIO
$16.6B
| $335K | 0.27% |
+9,700
| New | +$327K |
|
43
Madrigal Pharmaceuticals
MDGL
$11.9B
| $316K | 0.26% |
955
+5
| +0.5% | +$1.64K |
|
44
Okta
OKTA
$26.2B
| $316K | 0.26% |
3,000
| – | – |
|
45
Cloudflare
NET
$111B
| $282K | 0.23% |
2,500
| – | – |
|
46
Zscaler
ZS
$28.6B
| $281K | 0.23% |
1,415
| – | – |
|
|
MRUS
47
DELISTED
Merus
MRUS
| $268K | 0.22% |
+6,368
| New | +$278K |
|
48
Core Scientific
CORZ
$6.25B
| $261K | 0.21% |
+36,000
| New | +$410K |
|
49
Exelixis
EXEL
$13.1B
| $246K | 0.2% |
6,650
-950
| -13% | -$33.9K |
|
50
BILL Holdings
BILL
$4.91B
| $242K | 0.2% |
+5,272
| New | +$355K |
|
Similar funds
NIM
HCM
IWP
CD
JE
JMNC
BI
GW
Kazazian Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, Kazazian Asset Management held 79 positions worth $123M, down 6% from $131M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Kazazian Asset Management's Q1 2025 filing shows 18 new, 10 increased, 9 reduced and 20 closed positions. Its largest new stake was AdvisorShares Pure US Cannabis ETF: 712,558 shares worth $1.86M. The largest sale was State Street SPDR S&P Biotech ETF, an estimated $2.87M.
By sector, the portfolio is most concentrated in Communication Services at 33% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Financials.
- Kazazian Asset Management's largest Q1 2025 buy was AdvisorShares Pure US Cannabis ETF: 712,558 shares worth $1.86M.
- Kazazian Asset Management added most to Alphabet (Google) Class C in Q1 2025, an estimated $4.58M increase.
- Kazazian Asset Management's biggest Q1 2025 reduction was LegalZoom.com, cutting an estimated $1.83M.
- Kazazian Asset Management fully exited State Street SPDR S&P Biotech ETF in Q1 2025, selling an estimated $2.87M.
- Kazazian Asset Management's ten largest holdings make up 74% of its $123M portfolio in Q1 2025.
- Kazazian Asset Management opened 18 new positions and closed 20 in Q1 2025.
- Kazazian Asset Management's portfolio value fell 6% quarter-over-quarter to $123M.
Based on Kazazian Asset Management's 13F filing for Q1 2025, filed 9 May 2025.